Pfizer’s Experimental COVID-19 Vaccine 90 Percent Effective?
The German biotech firm BioNTech SE issued a joint press release with its American partner Pfizer, Inc. on Nov. 9, 2020 to announce that interim analysis of a global Phase 3 study of their mRNA-based SARS-CoV-2 vaccine appeared to demonstrate an efficacy rate “above 90%”measured seven days after the second dose.1 “This is really a […]
Another Shot at a Vaccine for Lyme Disease
The U.S. National Institutes of Health (NIH) has provided the University of Maryland with a $3.5 million dollar grant to develop a vaccine for Lyme disease.1 Principal investigators Utal Pal, PhD, professor at the Virginia-Maryland College of Veterinary Medicine at the University of Maryland College of Agriculture and Natural Resources and Matthias Schnell, PhD, director […]
Flu Shot Deaths in South Korea Said to Be “Coincidental”
Story Highlights More than 80 people have died in South Korea following influenza vaccination. After an investigation into the safety of the vaccines, South Korean health authorities ruled the deaths as “coincidental.” The public health agency in South Korea has decided to continue and promote its free influenza vaccine program despite public anxiety relating to […]
CureVac’s COVID-19 Vaccine Produces Grade 3 Adverse Events
Biopharmaceutical company CureVac NV of Tübingen, Germany has released the interim results of its Phase 1 clinical trial on its experimental CVnCoV vaccine COVID-19. The vaccine, which was given to more than 250 healthy adults 18 to 60 years of age, is based on messenger ribonucleic acid (mRNA) technology.1 2 Unlike traditional vaccines, mRNA vaccines […]
CDC Gives States COVID-19 Vaccination Program “Playbook”
The U.S. Centers for Disease Control (CDC) created a national COVID-19 Vaccine Program Playbook for state, territorial and local public health officials and their partners and issued directions for how to plan and operationalize COVID-19 vaccine programs in their jurisdictions. State health departments throughout the United States submitted comprehensive drafts of their COVID-19 vaccine distribution […]
Brazilian Doctor Dies Participating in AstraZeneca’s COVID-19 Vaccine Clinical Trial
Story Highlights A COVID-19 vaccine trial participant, who was a physician working with COVID-19 patients at hospitals in Brazil, has reportedly died from coronavirus infection complications. It has not been confirmed, but sources indicate the victim was given the trial “placebo” (a meningococcal vaccine) and not the experimental AZD1222 vaccine developed by pharmaceutical company AstraZeneca […]
